Why Skipping Patent Validity Analysis Can Derail Enforcement: Lessons From Landmark Patent Disputest
Introduction Patent owners often assume that once a patent has been granted, it automatically becomes a strong weapon for enforcement, licensing, and commercialization. In reality, a granted patent is only as valuable as its ability to withstand scrutiny when challenged. Every real infringement action almost inevitably triggers a counterattack questioning the Validity of the asserted […]
Patent Licensing in Asia-Pacific: Why India and South Korea Lead
Introduction Historically, international technology markets relied on a clear division of labor: Western focused on innovation, while Eastern handled manufacturing. The intellectual property rights remained in the hands of US and European corporations. The Asia-Pacific region has developed from a manufacturing hub to a major center of innovation. The World Intellectual Property Organization (WIPO) 2025 […]
From Litigation to Liquidity: Why Patent Licensing Became the Preferred Monetisation Tool in 2026
Introduction: Patents are instruments of exclusion. That has been their defining commercial identity since modern patent systems came into play. A patent gives its owner the right to stop others from “making, using, and selling” the patented invention without his/her authorization. It follows naturally that the enforcement of patents and the assertion of these exclusionary […]
What Is Double Patenting? A Guide to ODP, Patent Rejections, and Terminal Disclaimers
Introduction: What Is Double Patenting and Why Does It Matter in Patent Prosecution What happens when you spend years creating your invention, file several patent applications protecting various elements of your invention, and finally receive an objection by the patent examiner that you are trying to patent the same invention twice? That is where double […]
Apple vs. Optis: Reshaping the Rules of Standard Patent Licensing and FRAND Royalties
Introduction APPLE vs. OPTIS – Reshaping the Rule of Standard Patent Licensing Every time we share a video, open a map, send a message on your iPhone, your device is constantly in the process of negotiating with cell towers and this process involves using a complex set of protocols that are technical in nature. The […]
Why Skipping Patent Validity Analysis Can Derail Enforcement: Real – World Case Studies
Introduction Imagine pointing a gun at your biggest enemy, pulling the trigger, and having the barrel explode in your own hands. In the highly competitive world of intellectual property, this happens far more than you think. Everyday aspiring companies spend thousands or millions of dollars securing their patent. They receive a fascinating printed certificate from […]
Xilinx Patent Portfolio – Exemplary Landscape Overview
Xilinx is a leading technology company focused on innovation and creating and monetizing its Intellectual Property across jurisdictions. This exemplary study/report presents a high-level brief analysis of the Patent Portfolio of the Corporate, and various attributes/parameters on which the said entities Patent Portfolio is being represented. Xilinx along with its key subsidiaries has a total […]
Audi Patent Portfolio – Exemplary Landscape Overview
Audi is a leading technology company focused on innovation and creating and monetizing its Intellectual Property across jurisdictions. This exemplary study/report presents a high-level brief analysis of the Patent Portfolio of the Corporate, and various attributes/parameters on which the said entities Patent Portfolio is being represented. Audi along with its key subsidiaries has a total […]
Compulsory Licences and its Importance Worldwide in Patents Regime
HEPATITIS C – VACCINE AND PATENT Gilead Sciences’ sofosbuvir, a drug for Hepatitis C was approved in 2013 by US Food & Drug Administration was immediately criticized for its high cost as its price is so elevated relative to production cost.23 The average cost of a 12-week treatment of sofosbuvir is $84,000 per patient, despite […]
The Effect of the New Patent Amendment on Pharmaceutical Companies
INTRODUCTION Whether the Indian pharmaceutical firms are indeed innovating in developing new drugs or just incrementally improving the existing drugs to gain patents and arrive on the drug market. Indian Pharmaceutical Industry: regained focus on research and development, having turned out as the fourth largest in the world in volume terms (8% of global production) […]